ArticleAntimicrobial agents and chemotherapy1997

In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.

H Thadepalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.